<?xml version='1.0' encoding='utf-8'?>
<document id="14872546"><sentence text="Development and validation of a hydrophilic interaction liquid chromatography-tandem mass spectrometric method for the analysis of paroxetine in human plasma."><entity charOffset="131-141" id="DDI-PubMed.14872546.s1.e0" text="paroxetine" /></sentence><sentence text="A sensitive, simple, fast and rugged hydrophilic interaction liquid chromatography-tandem mass spectrometry (HILIC-MS/MS) method for the determination of paroxetine was developed and validated over curve range 0"><entity charOffset="154-164" id="DDI-PubMed.14872546.s2.e0" text="paroxetine" /></sentence><sentence text="050-50 ng/mL using only 0" /><sentence text="4 mL plasma" /><sentence text=" This is the first published LC-MS/MS method and the low limit of quantitation of this method is 10-fold lower than previously published methods" /><sentence text=" A simple liquid-liquid extraction method using methyl-tert butyl ether (MTBE) as the extraction solvent was used to extract paroxetine and the internal standard (IS) fentanyl-d(5) from plasma"><entity charOffset="48-71" id="DDI-PubMed.14872546.s6.e0" text="methyl-tert butyl ether" /><entity charOffset="73-77" id="DDI-PubMed.14872546.s6.e1" text="MTBE" /><entity charOffset="125-135" id="DDI-PubMed.14872546.s6.e2" text="paroxetine" /><pair ddi="false" e1="DDI-PubMed.14872546.s6.e0" e2="DDI-PubMed.14872546.s6.e0" /><pair ddi="false" e1="DDI-PubMed.14872546.s6.e0" e2="DDI-PubMed.14872546.s6.e1" /><pair ddi="false" e1="DDI-PubMed.14872546.s6.e0" e2="DDI-PubMed.14872546.s6.e2" /><pair ddi="false" e1="DDI-PubMed.14872546.s6.e1" e2="DDI-PubMed.14872546.s6.e1" /><pair ddi="false" e1="DDI-PubMed.14872546.s6.e1" e2="DDI-PubMed.14872546.s6.e2" /></sentence><sentence text=" The extract was evaporated to dryness, reconstituted and injected onto a silica column using a low aqueous-high organic mobile phase"><entity charOffset="74-80" id="DDI-PubMed.14872546.s7.e0" text="silica" /></sentence><sentence text=" The chromatographic run time was 2" /><sentence text="0 min per injection, with retention times of 1" /><sentence text="1 and 1" /><sentence text="2 min for paroxetine and IS, respectively"><entity charOffset="10-20" id="DDI-PubMed.14872546.s11.e0" text="paroxetine" /></sentence><sentence text=" The detection was by monitoring paroxetine at m/z 330 --&gt; 192 and IS at m/z 342 --&gt; 188, respectively"><entity charOffset="33-43" id="DDI-PubMed.14872546.s12.e0" text="paroxetine" /></sentence><sentence text=" The inter-day precision and accuracy of the quality control (QC) samples were &lt;5" /><sentence text="0% relative standard deviation (RSD) and &lt;2" /><sentence text="9% relative error (RE)" /><sentence text=" This method can be used for supporting therapeutical drug monitoring and pharmacokinetic or drug-drug interaction studies" /><sentence text="" /></document>